Vivek Charu

Please help us bring hope and light into this Holiday Season. One of our @StanfordNeph @StanfordAbdTxp faculty families is working to save their child’s life from a rare genetic condition. Please read, share and support. rarebreak.org

Prevalence of the M1 Modifier p.N264K in APOL1 Among Individuals With Kidney Disease Undergoing Commercial Genetic Testing in the United States bit.ly/48PB2xk (FREE) @BhallaResearch @gchertow @DianneKeenkim @vcharuMD

Excited to share this important work with the community. Effect of Starting Dialysis Versus Continuing Medical Management on Survival and Home Time in Older Adults With Kidney Failure: <span class="subtitle">A Target Trial Emulation Study</span> #fva1-M233028" target="_blank" rel="nofollow noopener">acpjournals.org/doi/10.7326/M2…

Amazing nephrology statistics session this morning at the ASA JSM meeting. Thank you to all the presenters for a great session on GFR slope estimation.

ORIGINAL ARTICLE Charu V et al. Benchmarking clinical risk prediction algorithms with ensemble machine learning for the non-invasive diagnosis of liver fibrosis in NAFLD #LiverTwitter @WRayKimMD

📢 New research underscores the critical role of pangenomic sequencing in patients with High-Risk APOL1 Genotypes for screening a Mendelian kidney disease. —>It highlights the importance of keeping an open mind. kireports.org/article/S2468-… #KidneyDisease #APOL1 @Laurent_Mesnard

Alternative metrics to summarize survival data are underused. This Perspective describes the statistical properties of the restricted mean survival time (RMST) and highlights advantages of the RMST metric in research bit.ly/CJASN0323 @MontezRath @ManjulaKTamura @vcharuMD

Clear criteria to individualize glycemic targets in patients with type II diabetes are lacking. This study shows that the effects of intensive glycemic control vary with risk of kidney failure, as predicted by the kidney failure risk equation bit.ly/JASN0272

The Association of Class I and II Human Leukocyte Antigen Serotypes With ESKD Due to Membranoproliferative Glomerulonephritis and Dense Deposit Disease buff.ly/3SM5Wyg (FREE temporarily) @MichelleOShaug3 @gchertow @vcharuMD @StanfordPath @StanfordNeph

Criteria to individualize glycemic targets in patients with type II diabetes are lacking. This study found heterogenous treatment effects of intensive glycemic control on microvascular outcomes in ACCORD as a function of predicted risk of kidney failure bit.ly/JASN0272

In CKD adults treated in @DeptVetAffairs, BP control declined from 78%-71% from 2011-2015, then increased... #KidneyInCVD @MontezRath @kingpaoman @enricaf @vcharumd @jaejin_an1 @JJSim008 @ManjulaKTamura @VAPaloAlto @KPSCalResearch @StanfordNeph @enricaf2 ahajrnls.org/49JiNrn

The Association of Class I and II Human Leukocyte Antigen Serotypes With ESKD Due to Membranoproliferative Glomerulonephritis and Dense Deposit Disease bit.ly/40fXFEZ @MichelleOShaug3 @gchertow @vcharuMD @StanfordPath @StanfordNeph

@Stanfordneph PhD student June Li representing our RELATE study group crushing it at her first poster presentation with #Kidneystars ⁦@StanfordEpiNews⁩ ⁦@MontezRath⁩ ⁦@kingpaoman⁩ ⁦@enricaf2⁩ @JJSim008 ⁦@vcharuMD⁩ ⁦@jaejin_an1⁩

Clinical trials and observational studies in nephrology often evaluate the effect of treatment on time-toevent outcomes. This Perspective illustrates the value of reporting the RMST and the RMST difference in nephrology survival data analysis bit.ly/CJASN0323

📖 This weekend don't miss our @KIReports #ISNFridaySelection: Challenges in IgA Nephropathy Management: An Era of Complement Inhibition kireports.org/article/S2468-…

The latest issue of Surgical Pathology Clinics focuses on diagnostic criteria, differential diagnosis, practice guidelines, challenges, and pitfalls associated with liver diseases. surgpath.theclinics.com/article/S1875-…

The Wilson lab at the University of Pennsylvania has opened its doors and we are hiring! Positions available for a postdoc and research specialist - check out our website for more details! Please RT parkerwilsonlab.com/positions/